This is consistent with the matching expression of Cebpa in these two contexts (1.1 ± 0.24 vs. 1.0 ± 0.13 (relative expression) in Cebpap30/p30 and CebpaΔ/p30Tet2+/+ AML blasts n = 3/group, respectively). The gene discussed is CEBPA; the disease is acute myeloid leukemia.